- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
19 result(s) found for: Autograft.
Displaying page 1 of 1.
EudraCT Number: 2010-018866-21 | Sponsor Protocol Number: Protocollo FLR/R 2510 | Start Date*: 2010-07-19 | |||||||||||
Sponsor Name:A.I.L. (ASSOCIAZIONE ITALIANA CONTRO LE LEUCEMIE, LINFOMI E MIELOMI | |||||||||||||
Full Title: Intensified program including Bendamustine followed by PBSC mobilization and high dose therapy and autograft for patients with relapsed or resistant CD 20+ Follicular Non Hodgkin Lymphoma: a multi... | |||||||||||||
Medical condition: RESISTANT FOLLICULAR NON HODGKIN LYNPHOMA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004296-19 | Sponsor Protocol Number: NBS07.116 | Start Date*: 2008-02-07 | |||||||||||
Sponsor Name:Association of Dutch Burn Centres | |||||||||||||
Full Title: Application of cultured autologous keratinocytes in combination with a meshed split skin autograft for burn wound healing | |||||||||||||
Medical condition: Even standard treatment, transplantation with a (meshed) split skin autograft, does not result in satisfactory functional and cosmetic appearance of the healed wound. Due to limited available donor... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005584-24 | Sponsor Protocol Number: PREOB-NU3 | Start Date*: 2012-05-10 | |||||||||||
Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
Full Title: A pivotal Phase IIb/III, multicentre, randomised, open, controlled study on the efficacy and safety of autologous osteoblastic cells (PREOB®) implantation in non-infected hypotrophic non-union frac... | |||||||||||||
Medical condition: Non-infected hypotrophic non-union fractures of long bones | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012583-13 | Sponsor Protocol Number: gamma delta | Start Date*: 2009-10-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Phase II study of interleukin-2 and zoledronic acid as maintenance therapy in patients with multiple myeloma having undergone autograft | |||||||||||||
Medical condition: Patients with multiple myeloma having undergone autograft | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000675-34 | Sponsor Protocol Number: EU 101 | Start Date*: 2004-12-21 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: A Prospective, Randomized, Controlled, Multi-center, (Pilot) Study of Osigraft® in Instrumented Posterolateral Fusions | ||
Medical condition: Subjects qualifying for decompression and fusion of one spinal level (L3-S1) with the use of autograft will be recruited through the medical institutions of participating investigators. All subject... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004034-11 | Sponsor Protocol Number: GR-OG-279239-04 | Start Date*: 2022-05-18 | ||||||||||||||||
Sponsor Name:Genera Research Ltd | ||||||||||||||||||
Full Title: A randomized, evaluator-blinded, dose-ranging, proof of concept study of efficacy, safety and tolerability of Osteogrow-C (rhBMP6 delivered in autologous blood coagulum [ABC] supplemented with sy... | ||||||||||||||||||
Medical condition: The treatment of non-union of the tibia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003627-38 | Sponsor Protocol Number: CD-2019/02 | Start Date*: 2019-11-12 | |||||||||||
Sponsor Name:Centre Georges-François Leclerc | |||||||||||||
Full Title: 18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myeloma | |||||||||||||
Medical condition: Patient with multiple myeloma, addressed for initial evaluation and eligible for an autograft of Hematopoietic Stem Cells. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003066-24 | Sponsor Protocol Number: MW2012-01-01 | Start Date*: 2014-12-17 | |||||||||||
Sponsor Name:MediWound Ltd. | |||||||||||||
Full Title: A multicenter, multinational, randomized, controlled, open label study, performed in children with thermal burns, to evaluate the efficacy and safety of NexoBrid as compared to standard of care (SO... | |||||||||||||
Medical condition: The study objective is to evaluate the safety and clinical benefit of NexoBrid in hospitalized children (0-18 years) with deep partial and/or full thickness thermal burns of 1-30% TBSA and to compa... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Ongoing) SK (Completed) DE (Ongoing) BE (Completed) AT (Prematurely Ended) BG (Prematurely Ended) NL (Prematurely Ended) FR (Ongoing) SE (Ongoing) GB (GB - no longer in EU/EEA) HU (Completed) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003409-98 | Sponsor Protocol Number: HERA-05/001 | Start Date*: 2006-02-09 |
Sponsor Name:Hôpital Erasme, Cliniques Universitaires de Bruxelles | ||
Full Title: Enhancement by tacrolimus of nerve regeneration after peripheral nerve repair. | ||
Medical condition: Patients presenting a total section of a major nerve at the arm, forearm, or leg, and treated by conventional nerve suture under microscope within ten days of the trauma. Patients with nerve autogr... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004047-23 | Sponsor Protocol Number: 273551-2 | Start Date*: 2019-12-05 |
Sponsor Name:University of Bergen | ||
Full Title: Evaluation of safety and feasibility of autologous MSCs combined to biomaterial to enhance bone healing in patients with delayed consolidation after long bone defects requiring graft apposition or ... | ||
Medical condition: Diaphyseal and/or metaphysodiaphyseal fractures (femur, tibia, humerus) status delayed union (after 3 months) treated by standard care procedures | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005890-24 | Sponsor Protocol Number: HM05/7287 | Start Date*: 2007-11-02 | |||||||||||
Sponsor Name:Leeds Teaching Hospitals NHS Trust | |||||||||||||
Full Title: Myeloma X Relapse (Intensive) - A randomised controlled trial to determine the role of a second autologous stem cell transplant as consolidation therapy in patients with relapsed multiple myeloma f... | |||||||||||||
Medical condition: Relapsed myeloma previously treated with chemotherapy and autologous stem cell transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001782-18 | Sponsor Protocol Number: MRZ 92579-0404/1 | Start Date*: 2005-02-14 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Saftey and efficacy of two different doses of Neramexane mesylate as preemptive analgesic and add-on therapy to opioids in the management of postoperative pain. A randomised, double-blind, placebo-... | |||||||||||||
Medical condition: Moderate to severe acute postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002383-13 | Sponsor Protocol Number: Cord_Blood_Expansion_(SR-1) | Start Date*: 2016-10-18 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Umbilical cord blood transplantation in high-risk hematological patients using stemregenin-1 expanded hematopoietic stem cells. A feasibility study focussing on engraftment and hematopoietic recov... | |||||||||||||
Medical condition: Patients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donor | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001554-24 | Sponsor Protocol Number: Protocolen°04.004.01/IFM200502 | Start Date*: 2007-04-24 | ||||||||||||||||
Sponsor Name:CHU de TOULOUSE | ||||||||||||||||||
Full Title: INTERET D’UN TRAITEMENT D’ENTRETIEN PAR REVLIMID APRES AUTOGREFFE DE CELLULES SOUCHES CHEZ LES PATIENTS DE MOINS DE 65 ANS ATTEINTS DE MYELOME (Essai de phase III, multicentrique, randomisé, double... | ||||||||||||||||||
Medical condition: Myélome de novo stade DS : III, II, I with one symptomatic bone ogique) No sign of cardia insufficiency and echography must schow FEV> 40 %. no hepatic insufficiency : bilirubine< 35µmol/L and ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020868-38 | Sponsor Protocol Number: RV-WM-PI-0548 | Start Date*: 2011-06-14 | |||||||||||
Sponsor Name:U.O.C. EMATOLOGIA - OSP. S. EUGENIO - ASL RM C | |||||||||||||
Full Title: (A Phase 2) STUDY TO DETERMINE THE EFFICACY AND SAFETY OF LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE (Rd) FOLLOWED BY RITUXIMAB, AUTOGRAFT AND LENALIDOMIDE MAINTENANCE IN NEWLY DIAGNOSED WALDESTROM MA... | |||||||||||||
Medical condition: Waldenstr�m`s Macroglobulinemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013798-16 | Sponsor Protocol Number: | Start Date*: 2010-02-01 | |||||||||||||||||||||||||||||||
Sponsor Name:Royal Liverpool and Broadgreen University Hospitals NHS Trust | |||||||||||||||||||||||||||||||||
Full Title: A comparison of plerixafor/G-CSF with chemotherapy/G-CSF for stem cell transplantation | |||||||||||||||||||||||||||||||||
Medical condition: Patients with lymphoma or myeloma, who require high dose chemotherapy with autologous stem cell rescue (known colloquially as an autograft). Plerixafor is used to mobilise the autologous stem cells... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002147-20 | Sponsor Protocol Number: RG-19-110 | Start Date*: 2020-11-11 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: A randomised, open-label, multicentre,phase III trial of in vivo purging with anti-CD38 (Daratumumab) to enhance myeloma autografting | |||||||||||||
Medical condition: Newly diagnosed Multiple Myeloma (MM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004644-70 | Sponsor Protocol Number: | Start Date*: 2010-11-22 | |||||||||||
Sponsor Name:GOELAMS | |||||||||||||
Full Title: Etude de phase III ouverte, randomisée portant sur l’intérêt d’un traitement d’entretien par rituximab en post-autogreffe dans le traitement des lymphomes à cellules du manteau chez des patients âg... | |||||||||||||
Medical condition: Traitement d'entretien de patients porteur d'un lymphome du manteau en réponse. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003662-41 | Sponsor Protocol Number: MW-2004-11-02 | Start Date*: 2005-11-24 |
Sponsor Name:MediWound Ltd | ||
Full Title: Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of Care (Protocol MW 2004-11-02) | ||
Medical condition: Burn wounds defined as deep partial thickness or full thickness thermal burns. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) SK (Ongoing) PT (Completed) CZ (Completed) IT (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.